Eli Lilly & Co. (LLY)

Health Care·equity

$1174.58

+0.43% today

Prices delayed about 15 minutes · cached page, can be an hour old or more

Tapeline Score

57/ 100

Score level

Above average

6 of 6 checks had data

Smart-money score is below the middle; business numbers score (revenue, margins, returns) is near the top of its range; and price trend score is above the middle.

LLY scores higher than 81% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Eli Lilly & Co. (LLY) scores 57 out of 100 on the Tapeline six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.34× 30-day average
52-week range: 783.85 – 1292.65
Market cap: $1.09T
Earnings date: 29 Oct 2026
Dividend yield: 0.75%

Volume: 799,538
Avg. volume (30d): 2,347,727

Open: 1153.56
Previous close: 1169.60
Day's range (regular session): 1151.67 – 1179.82

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 0.42
P/E (TTM): 41.01
EPS (TTM): 29.80

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for LLY

20 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Tapeline holds for LLY. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about LLY right now

Eli Lilly & Co. (LLY) currently scores 57/100 on the Tapeline six-factor composite, at the Above average score level. LLY is +0.43% on the day and +1.72% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for LLY leans good, with some weak spots. LLY's strongest factor is company finances at 83/100 — a very strong read on the company's own reported numbers. A high reading doesn't promise a near-term move. The weakest factor is insider trades at 11/100 — a well below average read on insider buying and selling. Insider filings for LLY lean toward selling; on a thinly filed name a few filings can set this reading.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See LLY in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score